Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.

Pediatrics - 1 Apr 2021

Mullins Eric S, Geer Rebecca, Metcalf Megan, Piccola Jeanne, Lane Adam, Conard Lee Ann E, Mullins Tanya L Kowalczyk

Abstract excerpt

BACKGROUND AND OBJECTIVES: Many transgender youth experience gender dysphoria, a risk factor for suicide. Gender-affirming hormone therapy (GAHT) ameliorates this risk but may increase the risk for thrombosis, as seen from studies in adults. The aim with this study was to examine thrombosis and thrombosis risk factors among an exclusively adolescent and young adult transgender population. METHODS: This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Anticoagulants
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gonadal Steroid Hormones

Share to Obesity

Share to Risk Factors

Share to Thrombosis

Share to Young Adult

Source

Identifiers

PMID: 33753543
DOI: 10.1542/peds.2020-023549

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.PMID 33753543Read ↗

Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation.Semantic proximity Read ↗

Pregnancy in Transmasculine, Non-binary, and Gender Expansive PatientsSemantic proximity Read ↗

Risks and benefits of estrogen therapy for a male-to-female transsexual with a prothrombin gene mutation.Semantic proximity Read ↗

Evaluation of potential adverse effects of gender-affirming hormonal therapy; findings from the Spanish Pharmacovigilance System DatabaseSemantic proximity Read ↗

Difficulties of gender affirming treatment in trans women with BRCA1+ mutation: A case report.Semantic proximity Read ↗

Transgenderism and reproductionSemantic proximity Read ↗

Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation.Semantic proximity Read ↗

Oocyte cryopreservation and reciprocal in vitro fertilization in a transgender man on long term testosterone gender-affirming hormone therapy: a case reportSemantic proximity Read ↗

Oocyte cryopreservation in a transgender man on long-term testosterone therapy: a case reportSemantic proximity Read ↗

Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram.Semantic proximity Read ↗

Pediatric Hematology Providers’ Contraceptive Practices for Female Adolescents and Young Adults with Sickle Cell Disease: A national surveySemantic proximity Read ↗

Lower levels of social support are associated with risk for future suicide attempts in a clinical sample of transgender and gender diverse adultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.